
Therapeutic Advances in Medical Oncology, Год журнала: 2024, Номер 16
Опубликована: Янв. 1, 2024
Patients with genitourinary (GU) malignancies have seen the development of multiple life-prolonging treatments in past decade. As patients and clinicians consider their treatment options along cancer journey, time spent healthcare contact, or "time toxicity," has emerged as a new outcome measure that comprehensively considers receiving care, including planned visits for evaluation well unplanned urgent care addressing complications. Despite its rising study across populations, there been surprising lack work evaluating toxicity GU cancers. This narrative review aims to summarize available studies on cancer, deeper dive into methodology, strengths limitations, future directions field. A dedicated section focused scenarios best practices collect data can serve spark interest this novel health survivors. Ultimately, is relevant patient-centered metric be incorporated clinical trial design routine influence decision-making.
Язык: Английский